These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15347726)

  • 1. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
    Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
    J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
    Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
    Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
    J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression.
    Chen L; Altman A; Mier W; Lu H; Zhu R; Haberkorn U
    Nucl Med Biol; 2006 May; 33(4):575-80. PubMed ID: 16720251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter.
    Kim KI; Chung JK; Kang JH; Lee YJ; Shin JH; Oh HJ; Jeong JM; Lee DS; Lee MC
    Clin Cancer Res; 2005 Jan; 11(1):123-8. PubMed ID: 15671536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
    Schipper ML; Riese CGU; Seitz S; Weber A; Béhé M; Schurrat T; Schramm N; Keil B; Alfke H; Behr TM
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):638-650. PubMed ID: 17160413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a dual membrane protein reporter system using sodium iodide symporter and mutant dopamine D2 receptor transgenes.
    Hwang DW; Kang JH; Chang YS; Jeong JM; Chung JK; Lee MC; Kim S; Lee DS
    J Nucl Med; 2007 Apr; 48(4):588-95. PubMed ID: 17401096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
    Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
    J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
    Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
    PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression.
    Kang JH; Lee DS; Paeng JC; Lee JS; Kim YH; Lee YJ; Hwang DW; Jeong JM; Lim SM; Chung JK; Lee MC
    J Nucl Med; 2005 Mar; 46(3):479-83. PubMed ID: 15750162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
    Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
    J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
    Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
    Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
    Jin YN; Chung HK; Kang JH; Lee YJ; Kimm KI; Kim YJ; Kim S; Chung JK
    Cancer Biother Radiopharm; 2008 Oct; 23(5):551-60. PubMed ID: 18986218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
    Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.